THE VAT TRAP BLUEPRINT · PANEL 6 OF 6
The options
6
Time-restricted eating, longer fasts, keto and the GLP-1 medicines. Useful for some, mandatory for none — and none of them a substitute for the bedrock.
The one-line version. Everything on this page is optional. What these approaches mostly do is make the five bedrock parts easier to keep — which is the only good reason to take one on. Run each through the forever test first: if you cannot see yourself doing it in ten years, it is a holiday, not a plan.
Why this one is optional
The bedrock is where the evidence is strongest and the demands are lowest. The options are different: each has real supporting evidence, but mostly for weight or glucose rather than for visceral fat specifically, and each suits some people and makes others miserable. Misery is not a long-term plan. Treat them as scaffolding — something that holds the structure up while it is being built, and that the structure should eventually not need.
Time-restricted eating. An eight-to-ten hour window suits most. It works largely by closing the kitchen rather than by any magic in the clock — which is fine, if closing the kitchen is your problem.
Longer fasts. Some people find an occasional 24 hours genuinely useful; others find it wretched. Protein and strength work around them matter more, not less. Take advice first if you use insulin, a sulfonylurea or a GLP-1.
Keto, low-carb, Atkins. Can be powerful, particularly for the big spikers a CGM identifies. The question is never whether it works for twelve weeks; it is whether you can live inside it.
A GLP-1, at the lowest dose that works. Prescription only, with medical supervision. In our clinic a low dose is often enough where visceral fat is raised. Muscle must be defended throughout — adequate protein and resistance training alongside, without exception.
Scaffold, not substitute. The bedrock matters more on a GLP-1, not less.
Where the evidence runs out
The evidence thins out here, and it is worth saying where. Most time-restricted eating trials show benefits consistent with simply eating less, rather than an independent effect of timing. Low-carbohydrate approaches perform well in the short term and converge with everything else by about a year in most trials. And the GLP-1 medicines are the newest part of the picture: they work, but a substantial share of the weight lost is lean tissue unless it is actively defended, and the low-dose approach described here reflects our clinical experience rather than a licensed dosing schedule. None of this is a recommendation. Any decision about medication, heavy fasting or a major dietary change belongs with your own clinician, who knows what else you are taking.
THE EVIDENCE THAT SITS BEHIND THIS PANEL
Go as deep as you like
A Calorie is a Unit of Energy, Not a Unit of Biology
Why identical calories behave differently once they are inside you — and where that argument stops being supported by the evidence.
EVIDENCE NOTE
Which Type 2 Diabetes Is This? A VAT-Centred Framework
Why type 2 diabetes is not one disease, and how visceral fat separates the version that responds to this approach from the version that doesn't.
WHITE PAPER
THE EVIDENCE THAT SITS BEHIND THIS PANEL
Go as deep as you like
EVIDENCE NOTE
The Minimum Effective Dose of Resistance Training
Is ten minutes really enough? What the trials show for strength and metabolism — and where a low dose falls short, especially for bone after menopause.
Muscular Strength as a Clinical Vital Sign
Why grip strength and the sit-to-stand test belong in every check-up, with interpretation bands by age and sex.
WHITE PAPER
Preserving muscle on GLP-1 therapy through protein and resistance training — and why we measure what muscle does, not how much a scan says is there.
WHITE PAPER
Or explore the other panels: Measure · Protein & muscle · Regular movement · Rebalance the plate · Insulin
.png)